Market revenue in 2024 | USD 6,040.5 million |
Market revenue in 2030 | USD 6,765.8 million |
Growth rate | 2.3% (CAGR from 2025 to 2030) |
Largest segment | Antibacterials |
Fastest growing segment | Antifungals |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Antibacterials, Antivirals, Antifungals |
Key market players worldwide | Pfizer Inc, Abbott Laboratories, Gilead Sciences Inc, Bristol-Myers Squibb Co, Merck & Co Inc, Sandoz Group AG ADR, B. Braun, Novo Holdings, Mankind Pharma, Bayer AG, AstraZeneca PLC, Boehringer Ingelheim Pharma |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to anti-infective agents market will help companies and investors design strategic landscapes.
Antibacterials was the largest segment with a revenue share of 41.27% in 2024. Horizon Databook has segmented the Japan anti-infective agents market based on antibacterials, antivirals, antifungals covering the revenue growth of each sub-segment from 2018 to 2030.
Japan's anti-infective agents market is experiencing significant growth, driven by government funding and initiatives aimed at combating antimicrobial resistance (AMR) and supporting pharmaceutical innovation.
In October 2023, the Government of Japan announced an increase in funding for the Global Antibiotic Research & Development Partnership (GARDP) to bolster its crucial efforts in developing new treatments for drug-resistant infections and ensuring these treatments are accessible to those in need.
The Japanese government has launched various programs to enhance research and development in the field, providing financial assistance and incentives for companies engaged in creating new anti-infective therapies.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan anti-infective agents market , including forecasts for subscribers. This country databook contains high-level insights into Japan anti-infective agents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account